CCRN (Cross Country Healthcare) 3-Year RORE % : 190.79% (As of Mar. 2026)


CCRN Cross Country Healthcare Inc CCRN
53 GF Score
Price $13.20
GF Value $10.43
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cross Country Healthcare 3-Year RORE %?

Cross Country Healthcare CCRN 53 3-Year RORE % is 190.79 as of Mar. 2026. GuruFocus rates CCRN with a GF Score™ of 53/100 and a GF Value™ of $10.43 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Cross Country Healthcare ranks better than 95.21% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Cross Country Healthcare's 3-Year RORE % for the quarter that ended in Mar. 2026 was 190.79%.

The industry rank for Cross Country Healthcare's 3-Year RORE % or its related term are showing as below:

CCRN's 3-Year RORE % is ranked better than
95.21% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs CCRN: 190.79

Cross Country Healthcare  (NAS:CCRN) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Cross Country Healthcare 3-Year RORE % Related Terms


Cross Country Healthcare 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Cross Country Healthcare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cross Country Healthcare 3-Year RORE % Chart

Cross Country Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 329.49 65.65 -14.19 -82.30 372.93

Cross Country Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -95.16 -108.63 -145.18 372.93 190.79

CCRN vs SRTA, CYH, AUNA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Cross Country Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cross Country Healthcare 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cross Country Healthcare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Cross Country Healthcare's 3-Year RORE % falls into.


CCRN
53GF Score
Cross Country Healthcare Inc CCRN
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cross Country Healthcare 3-Year RORE % Calculation

Cross Country Healthcare's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -3.05-1.3 )/( -2.28-0 )
=-4.35/-2.28
=190.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 190.79 mean?
Cross Country Healthcare (CCRN) has a 3-Year RORE % of 190.79 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cross Country Healthcare and its competitors. According to the industry distribution chart, Cross Country Healthcare ranks #29 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 4.8%.
Is Cross Country Healthcare's 3-Year RORE % too high?
Cross Country Healthcare's current 3-Year RORE % is 190.79. Based on the distribution chart, Cross Country Healthcare ranks #29 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cross Country Healthcare has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's 3-Year RORE % compare to SRTA and CYH?
According to the Healthcare Providers & Services industry distribution chart, Cross Country Healthcare ranks #29 out of 605 companies for 3-Year RORE %. This places Cross Country Healthcare in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cross Country Healthcare and its competitors. Cross Country Healthcare's current 3-Year RORE % is 190.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cross Country Healthcare (CCRN) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.43, compared to a current price of $13.20 — trading 26.6% above its estimated fair value. The current 3-Year RORE % is 190.79. Cross Country Healthcare's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Cross Country Healthcare (CCRN), the current 3-Year RORE % is 190.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cross Country Healthcare (CCRN) Overvalued in 2026?

Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued. The current stock price of $13.20 is trading 26.6% above its estimated GF Value™ of $10.43. GuruFocus considers Cross Country Healthcare to be Modestly Overvalued.

Key valuation signals for CCRN:

  • 3-Year RORE %: 190.79
  • GF Value™: $10.43 vs. price of $13.20 (26.6% above fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the CCRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cross Country Healthcare Business Description

Address 5201 Congress Avenue, Suite 160, Boca Raton, FL, USA, 33487
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
53GF Score

Get the complete analysis for CCRN

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.20
Price
$10.43
GF Value